| Issue Date | Title | Author(s) |
| 2022-10-19 | Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life. | Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM |
| 2022-04 | Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer. | Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM |
| 2017-09 | Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer? | George, R; Haywood, A; Good, P; Hennig, S; Khan, S; Norris, R; Hardy, J |
| 2024-05-30 | Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
| 2017-07-03 | Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). | Vayne-Bossert, P; Haywood, A; Good, P; Khan, S; Rickett, K; Hardy, JR |
| 2023-01-23 | Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer. | Sandford, A; Haywood, A; Rickett, K; Good, P; Khan, S; Foster, K; Hardy, JR |
| 2019-03-04 | Managing diabetes at the end of life–a retrospective chart audit of two health providers in Queensland, Australia | Alqabandi, N; Haywood, A; Kindl, K; Khan, S; Good, P; Hardy, J |
| 2023-12-14 | Medically assisted hydration for adults receiving palliative care. | Buchan, EJ; Haywood, A; Syrmis, W; Good, P |
| 2024-05-01 | Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. | Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P |
| 2019-12-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) | Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J |
| 2020-07-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). | Hardy, J; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Good, P |
| 2021-03 | Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer. | Hardy, J; Haywood, A; Rickett, K; Sallnow, L; Good, P |
| 2016 | Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection. | George, R; Lobb, M; Haywood, A; Khan, S; Hardy, J; Good, P; Hennig, S; Norris, R |
| 2019-02-20 | Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults | Haywood, A; Duc, J; Good, P; Khan, S; Rickett, K; Vayne-Bossert, P; Hardy, JR |
| 2024-02-10 | The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life. | Haupt, LM; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Pharasi, A; Zunk, M; George, R; Griffiths, LR; Good, P; Hardy, J |
